Heterophylliin A | 87687-52-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 单宁
• 英文名称: Heterophylliin A
• 英文别名: [3,4,5,12,21,22,23-heptahydroxy-8,18-dioxo-13-(3,4,5-trihydroxybenzoyl)oxy-9,14,17-trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-hexaen-11-yl] 3,4,5-trihydroxybenzoate
• CAS: 87687-52-3
• 化学式: C₃₄H₂₆O₂₂
• 分子量: 786.6
• InChiKey: NLDMNSXOCDLTTB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  56
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  377
• 氢给体数：
  13
• 氢受体数：
  22

文献信息

• COMPOUNDS, COMPOSITIONS AND METHODS FOR PROTECTING BRAIN HEALTH IN NEURODEGENERATIVE DISORDERS
  申请人：Amazetis SA

  公开号：EP3202399A1

  公开（公告）日：2017-08-09

  Aspects of the invention relate to compounds, extracts and compositions thereof, and methods of using of the same, to treat neurodegenerative disorders and/or improve brain health. In certain embodiments, said compounds are pomegranate flavonoids.

  本发明的各个方面涉及治疗神经退行性疾病和/或改善大脑健康的化合物、提取物及其组合物以及使用方法。在某些实施方案中，所述化合物是石榴类黄酮。
• Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders
  申请人：Rinsch Christopher L.

  公开号：US20110065662A1

  公开（公告）日：2011-03-17

  Aspects of the invention relate to compounds, extracts and compositions thereof, and methods of using of the same, to treat neurodegenerative disorders and/or improve brain health. In certain embodiments, said compounds are pomegranate flavonoids.
• Compounds, Compositions and Methods for Protecting Brain Health in Neurodegenerative Disorders
  申请人：Amazentis SA

  公开号：US20150196577A1

  公开（公告）日：2015-07-16

  Aspects of the invention relate to compounds, extracts and compositions thereof, and methods of using of the same, to treat neurodegenerative disorders and/or improve brain health. In certain embodiments, said compounds are pomegranate flavonoids.
• ANTICANCER AGENT, AND COMBINATION USE ANTICANCER AGENT
  申请人：Microbial Chemistry Research Foundation

  公开号：US20150283159A1

  公开（公告）日：2015-10-08

  An anticancer agent containing ellagitannin, a combination use anticancer agent wherein the anticancer agent and an anticancer agent containing anthracyclines are used in combination.
• US8933217B2
  申请人：——

  公开号：US8933217B2

  公开（公告）日：2015-01-13